𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine

✍ Scribed by Virgilio Gallai; Andrea Alberti; Cristiana Rossi; Francesca Coppola; Beatrice Gallai; Giovanni Mazzotta; Paola Sarchielli

Publisher
Springer
Year
2003
Tongue
English
Weight
92 KB
Volume
4
Category
Article
ISSN
1129-2369

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Open-label pilot study of levetiracetam
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease
✍ Theresa A. Zesiewicz; Kelly L. Sullivan; Robert A. Hauser; Juan Sanchez-Ramos πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 1 views

## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective open‐label pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo

Open-label pilot study of levetiracetam
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
✍ Theresa A. Zesiewicz; Kelly L. Sullivan; John L. Maldonado; William O. Tatum; Ro πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

## Abstract We evaluated the tolerability and preliminary efficacy of levetiracetam (LEV; Keppra) in reducing levodopa‐induced dyskinesias in Parkinson's disease (PD) in an open‐label pilot study. Nine PD patients who were experiencing peak‐dose dyskinesias for at least 25% of the awake day and wer